• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘氨醇-1-磷酸作为高密度脂蛋白处理诱导胰岛素分泌的关键因子。

Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatment.

机构信息

Division of Endocrinology, Diabetes, Nutrition and Patient Education, Department of Medicine, University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.

Unit of Toxicology, University Centre of Legal Medicine, Lausanne-Geneva, Switzerland.

出版信息

Physiol Rep. 2021 Mar;9(6):e14786. doi: 10.14814/phy2.14786.

DOI:10.14814/phy2.14786
PMID:33769715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7995544/
Abstract

Beta cell failure is one of the most important features of type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) has been proposed to improve β-cell function. However, the mechanisms involved in this process are still poorly understood. The aim of this study was to investigate the contribution of sphingosine-1-phosphate (S1P) in the impact of HDL treatment on insulin secretion by pancreatic β-cells and to determine its mechanisms. Primary cultures of β-cells isolated from rat were treated with or without HDL in the presence or absence of S1P pathway inhibitors and insulin secretion response was analyzed. The S1P content of HDL (HDL-S1P) isolated from T2DM patients was analyzed and correlated to the HDL-induced insulin secretion. The expression of genes involved in the biosynthesis of the insulin was also evaluated. HDL as well as S1P treatment enhanced glucose-stimulated insulin secretion (GSIS). In HDL isolated from T2DM patients, while HDL-S1P was strongly correlated to its pro-secretory capacity (r = 0.633, p = 0.005), HDL-cholesterol and apolipoprotein AI levels were not. HDL-induced GSIS was blocked by the S1P1/3 antagonist but not by the S1P2 antagonist, and was also accompanied by increased intracellular S1P in β-cells. We also observed that HDL improved GSIS without significant changes in expression levels of insulin biosynthesis genes. Our present study highlights the importance HDL-S1P in GSIS in T2DM patients and demonstrates that HDL induces insulin secretion by a process involving both intra- and extra-cellular sources of S1P independently of an effect on insulin biosynthesis genes.

摘要

β细胞衰竭是 2 型糖尿病(T2DM)的最重要特征之一。高密度脂蛋白(HDL)被认为可以改善β细胞功能。然而,这一过程中涉及的机制仍知之甚少。本研究旨在研究鞘氨醇-1-磷酸(S1P)在 HDL 处理对胰岛β细胞胰岛素分泌的影响中的作用,并确定其机制。用或不用 HDL 处理分离自大鼠的原代β细胞,在存在或不存在 S1P 途径抑制剂的情况下分析胰岛素分泌反应。分析来自 T2DM 患者的 HDL(HDL-S1P)中的 S1P 含量,并将其与 HDL 诱导的胰岛素分泌相关联。还评估了参与胰岛素生物合成的基因的表达。HDL 以及 S1P 处理增强了葡萄糖刺激的胰岛素分泌(GSIS)。在来自 T2DM 患者的 HDL 中,虽然 HDL-S1P 与它的促分泌能力强烈相关(r=0.633,p=0.005),但 HDL-胆固醇和载脂蛋白 AI 水平没有。HDL 诱导的 GSIS 被 S1P1/3 拮抗剂阻断,但不被 S1P2 拮抗剂阻断,并且还伴有β细胞内 S1P 的增加。我们还观察到 HDL 改善 GSIS,而胰岛素生物合成基因的表达水平没有显著变化。本研究强调了 HDL-S1P 在 T2DM 患者 GSIS 中的重要性,并表明 HDL 通过涉及细胞内外 S1P 来源的独立于对胰岛素生物合成基因的作用的过程诱导胰岛素分泌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/29ade6c68682/PHY2-9-e14786-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/aaea391fb3b0/PHY2-9-e14786-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/de6c4a2d99ce/PHY2-9-e14786-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/eedd856aa05f/PHY2-9-e14786-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/7cf55f8ccd36/PHY2-9-e14786-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/29ade6c68682/PHY2-9-e14786-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/aaea391fb3b0/PHY2-9-e14786-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/de6c4a2d99ce/PHY2-9-e14786-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/eedd856aa05f/PHY2-9-e14786-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/7cf55f8ccd36/PHY2-9-e14786-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/7995544/29ade6c68682/PHY2-9-e14786-g005.jpg

相似文献

1
Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatment.鞘氨醇-1-磷酸作为高密度脂蛋白处理诱导胰岛素分泌的关键因子。
Physiol Rep. 2021 Mar;9(6):e14786. doi: 10.14814/phy2.14786.
2
Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.鞘氨醇 1-磷酸(S1P)调节胰岛β细胞的葡萄糖刺激胰岛素分泌。
J Biol Chem. 2012 Apr 13;287(16):13457-64. doi: 10.1074/jbc.M111.268185. Epub 2012 Mar 2.
3
Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate.鞘氨醇-1-磷酸载体载脂蛋白M对胰岛素分泌的诱导作用。
Biochim Biophys Acta. 2014 Sep;1841(9):1217-26. doi: 10.1016/j.bbalip.2014.05.002. Epub 2014 May 9.
4
Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2.1-磷酸鞘氨醇通过1-磷酸鞘氨醇受体2亚型抵消胰腺β细胞中的胰岛素信号传导。
FASEB J. 2015 Aug;29(8):3357-69. doi: 10.1096/fj.14-263194. Epub 2015 Apr 24.
5
Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.肝载脂蛋白 M(apoM)过表达可刺激形成更大的 apoM/神经鞘氨醇 1-磷酸富含的血浆高密度脂蛋白。
J Biol Chem. 2014 Jan 31;289(5):2801-14. doi: 10.1074/jbc.M113.499913. Epub 2013 Dec 6.
6
High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.杂合子家族性高胆固醇血症中高密度脂蛋白相关的1-磷酸鞘氨醇活性
Eur J Clin Invest. 2017 Jan;47(1):38-43. doi: 10.1111/eci.12699. Epub 2016 Nov 30.
7
Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.低密度脂蛋白和高密度脂蛋白调节原代人及小鼠胰岛β细胞的功能、凋亡和增殖。
Endocrinology. 2009 Oct;150(10):4521-30. doi: 10.1210/en.2009-0252. Epub 2009 Jul 23.
8
High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.2 型糖尿病患者的高密度脂蛋白上调内皮细胞中环氧化酶-2 的表达和前列环素 I-2 的释放:与高密度脂蛋白相关的鞘氨醇-1-磷酸的关系。
Cardiovasc Diabetol. 2013 Jan 30;12:27. doi: 10.1186/1475-2840-12-27.
9
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.终末期肾病患者的高密度脂蛋白具有更好的心脏保护作用,并增加了鞘氨醇-1-磷酸。
Eur J Clin Invest. 2018 Feb;48(2). doi: 10.1111/eci.12866. Epub 2017 Dec 14.
10
To Be or Not to Be: The Divergent Action and Metabolism of Sphingosine-1 Phosphate in Pancreatic Beta-Cells in Response to Cytokines and Fatty Acids.是与否:细胞因子和脂肪酸对胰腺β细胞中鞘氨醇-1-磷酸的分歧作用和代谢。
Int J Mol Sci. 2022 Jan 31;23(3):1638. doi: 10.3390/ijms23031638.

引用本文的文献

1
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes.高密度脂蛋白在1型和2型糖尿病中的抗氧化及抗炎功能
Antioxidants (Basel). 2023 Dec 28;13(1):57. doi: 10.3390/antiox13010057.

本文引用的文献

1
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.终末期肾病患者的高密度脂蛋白具有更好的心脏保护作用,并增加了鞘氨醇-1-磷酸。
Eur J Clin Invest. 2018 Feb;48(2). doi: 10.1111/eci.12866. Epub 2017 Dec 14.
2
Overexpression of sphingosine-1-phosphate lyase protects insulin-secreting cells against cytokine toxicity.鞘氨醇-1-磷酸裂解酶的过表达可保护胰岛素分泌细胞免受细胞因子毒性的影响。
J Biol Chem. 2017 Dec 8;292(49):20292-20304. doi: 10.1074/jbc.M117.814491. Epub 2017 Oct 25.
3
The role of sphingolipid signalling in diabetes‑associated pathologies (Review).
鞘脂信号在糖尿病相关病理中的作用(综述)
Int J Mol Med. 2017 Feb;39(2):243-252. doi: 10.3892/ijmm.2017.2855. Epub 2017 Jan 11.
4
S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization.高密度脂蛋白中的1-磷酸鞘氨醇促进清道夫受体B1与1-磷酸鞘氨醇受体1之间的相互作用,并激活1-磷酸鞘氨醇受体1介导的生物学功能:钙流和1-磷酸鞘氨醇受体1内化。
J Lipid Res. 2017 Feb;58(2):325-338. doi: 10.1194/jlr.M070706. Epub 2016 Nov 23.
5
Dual Actions of Apolipoprotein A-I on Glucose-Stimulated Insulin Secretion and Insulin-Independent Peripheral Tissue Glucose Uptake Lead to Increased Heart and Skeletal Muscle Glucose Disposal.载脂蛋白A-I对葡萄糖刺激的胰岛素分泌及胰岛素非依赖的外周组织葡萄糖摄取的双重作用导致心脏和骨骼肌葡萄糖处置增加。
Diabetes. 2016 Jul;65(7):1838-48. doi: 10.2337/db15-1493. Epub 2016 Apr 19.
6
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.糖尿病与高密度脂蛋白鞘氨醇-1-磷酸含量降低及高密度脂蛋白对心脏细胞保护作用受损有关。
Arterioscler Thromb Vasc Biol. 2016 May;36(5):817-24. doi: 10.1161/ATVBAHA.115.307049. Epub 2016 Mar 10.
7
Apolipoprotein A-I interactions with insulin secretion and production.载脂蛋白A-I与胰岛素分泌及生成的相互作用。
Curr Opin Lipidol. 2016 Feb;27(1):8-13. doi: 10.1097/MOL.0000000000000253.
8
HDL and glucose metabolism: current evidence and therapeutic potential.高密度脂蛋白与葡萄糖代谢:当前证据及治疗潜力
Front Pharmacol. 2015 Oct 31;6:258. doi: 10.3389/fphar.2015.00258. eCollection 2015.
9
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications.高密度脂蛋白鞘氨醇-1-磷酸:心血管功能、疾病相关改变及治疗应用
Front Pharmacol. 2015 Oct 20;6:243. doi: 10.3389/fphar.2015.00243. eCollection 2015.
10
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.载脂蛋白高密度脂蛋白缺陷导致的冠状动脉疾病:通过鞘氨醇-1-磷酸加载进行纠正。
J Am Coll Cardiol. 2015 Sep 29;66(13):1470-85. doi: 10.1016/j.jacc.2015.07.057.